| Market Cap | ₹29Cr |
| ROE | 2.04% |
| P/E Ratio(TTM) | 33.95 |
| EPS(TTM) | 1.14 |
| P/B Ratio | 0.97 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.50 |
| Book Value | 39.72 |
| Debt to Equity | 0.69 |
| Face Value | 10 |
| Parent Organisation | Chandra Bhagat Pharma Limited |
| Managing Director | Hemant Chandravadan Bhagat |
| BSE Symbol | 542934 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.61 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.73 | ||
| Cohance Lifesciences | NA (0.00%) | 68.91 | ||
| Wockhardt | NA (0.00%) | -392.85 |